|
|
Article: Seeking success in the Red Zone
- Article from:
- Indianapolis Business Journal
- Article date:
- September 21, 2009
- Author:
CopyrightCopyright IBJ Corporation Sep 21, 2009. Provided by ProQuest LLC. (Hide copyright information)
|
Any armchair quarterback could recognize the problem Eli Lilly and Co. is having. It's struggling in the Red Zone.
The Indianapolis-based drugmaker has successfully moved experimental drugs into position to win approval by regulators. But only once in the last four years has a new drug actually made it to market - the drug industry's equivalent of a touchdown.
"I'd like to score more touchdowns," Lilly CEO John Lechleiter said.
The company restructuring announced Sept. 14 is Lechleiter's new playbook for doing just that.
Lechleiter will break Lilly into five business units - diabetes, cancer, animal health, emerging markets and established products - so each can focus on the scoring ...